Results (
Indonesian) 1:
[Copy]Copied!
Since, OXC is poorly water-soluble drug, its release fromthe MR tablets is incomplete and therapeutically effective druglevels may not be achieved for a MR dosage form. The obtaineddrug release profiles with F1-F7 explain this fact i.e. only between29-71% of OXC release was obtained with all these formulations.Hence, excipients in the category of solubilizing agents, likesurfactants (SLS), complex forming agents (cyclodextrin like β-CDand HP-β-CD) and solubilizing and channeling agents (PEG 6000)at levels of 10-20% w/w of the total tablet weight were included inthe formulations and their effect on the OXC release was studied inorder to achieve therapeutically effective levels of OXC
Being translated, please wait..
